Expert Comments:

Blake Desaulniers, Financial News Now (7/9/18) "Sproutly Inc. has made a deal for a breakthrough, patent pending discovery, whereby the active compounds, the tetrahydrocannabidiol and cannabidiols, in marijuana, are recovered in water to create a range of products to supply to the licensed producers and to the food and beverage industry. . .I can't overstate the importance of a natural product rather than a chemically altered one in this market space, hence, my position that the company is a category killer, if there ever was one!"
Not Your Ordinary Cannabis Company (7/8/18) Canada has passed legislation that will allow the sale of marijuana for recreational use beginning in October, and a Canadian cannabis company with access to a disruptive technology that creates water soluble cannabinoids is about to complete a reverse takeover and begin trading on the Canadian Securities Exchange on July 9. read more >
Benjamin Smith, Midas Letter (7/6/18) "Sproutly Inc., the world's first and only natural water soluble cannabis distiller, will begin trading on the Canadian Securities Exchange next Monday, bringing with it transcendent technology which could recast the cannabis sector as we know it. . .the company reformulated and improved upon a process which simultaneously solves the billion dollar onset/offset question while producing the most chemically unaltered end product and streamlined additive production process in the industry."
	Jason Hamlin, Gold Stock Bull (6/28/18) "Sproutly Inc. aims to be a vertically integrated cannabis consumer products company, bringing together pharma-grade cultivation, secured distribution solutions and advanced technologies to redefine the cannabis industry. It has not yet started trading but expects to in the next week or so. . .what excites me about the company is the patent it has pending for water soluble cannabis ingredients."
Robin Lefferts, CFN Media Group (6/22/18) "Sproutly Inc. is nearing completion of the acquisition of Infusion Biosciences, a company with Canadian and international rights to a proprietary technology platform for the extraction of water soluble cannabinoids. . .the company is going public very soon, giving investors a chance to get involved in a technology that is fundamentally disrupting cannabis science and some of the highest growth sectors in the market."
	Chris Parry, Equity Guru (6/22/18) "Sproutly Inc. got itself an acquisition in the pipeline; the company is called Infusion Biosciences, and it creates water soluble cannabis. . .Sproutly's level nine vault allows it to hold $32M in product, and its proximity to Toronto would allow it to offer two-hour delivery. It has a full lab on site with $500K in equipment."

Experts Following This Company

	Jason Hamlin, Founder – Gold Stock Bull
	Chris Parry – Equity Guru

The information provided above is from analysts, newsletters, the company and other contributors.

Sproutly Inc. is a sponsor of Streetwise Reports. The company's sponsorship fees pay for Streetwise Reports to create and update this "Investor Summary Page," to which links are placed on Streetwise Reports' websites and newsletters. Streetwise Reports does not accept stock for the payment of fees. See disclaimer for more details.

The company description, investing highlights and catalyst calendar on this page were prepared by the company. The Expert Comments and Experts Following This Company sections of this page are compiled by Streetwise Reports. There may be other information about the company that is not placed on this page. Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on this page.

The Expert Opinions above are excerpted from third-party sources not affiliated with or controlled by Streetwise Reports. The statements or opinions expressed in the Expert Opinions above are those of the authors indicated, and Streetwise Reports has not verified the accuracy of material excerpted here. Publications excerpted above may receive payment or sponsorship from the company mentioned.

Streetwise Reports does not provide investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security.Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.

Readers should conduct their own research for all information publicly available concerning the company.